Outcomes4me and labcorp study reveals digital education can increase her2-low awareness for metastatic breast cancer patients

Research to be presented in a joint poster session with labcorp at the 2024 san antonio breast cancer symposium boston and burlington, n.c. , nov. 26, 2024 /prnewswire/ -- outcomes4me inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awareness study, conducted with labcorp, a global leader of innovative and comprehensive laboratory services, at the prestigious 2024 san antonio breast cancer symposium (sabcs) on december 13, 2024.
LH Ratings Summary
LH Quant Ranking